A study in lung cancer patients for understanding distinct genetic characteristics for better diagnostics
Not Applicable
- Conditions
- Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
- Registration Number
- CTRI/2023/08/056271
- Lead Sponsor
- Avesthagen Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Male and female subjects diagnosed from lung cancer between the age of 40 to 65 years (both inclusive)
Exclusion Criteria
Diagnosed with any other cancer along with lung cancer.
Pregnant and lactating women need to be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aged-matched to predict biomarkers for lung cancer similar to epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), along with othersTimepoint: On the day of enrollment to this study
- Secondary Outcome Measures
Name Time Method Current & past health status assessed via Health QuestionnaireTimepoint: Baseline & at 7±1 day